Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-17-020952

VP, Chief Medical Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Friend John E. II VP, Chief Medical Officer 2017-04-17 Grant or award +100,000 100,000 D
Loading xslF345X03/v464509_form4.xml…